Although PSA density (PSAD) has shown a positive association with the risk of PCA, especially in patients with PSA levels of 4-10ng/mL, it has limited predictive power because it closely depends on distributions of prostate volumes ( 1 , 3 ). The gene discussed is KLK3; the disease is posterior cortical atrophy.